Companion Animal Drugs Market Size, Share, and Trends 2024 to 2034

The global companion animal drugs market size accounted for USD 15.77 billion in 2025 and is forecasted to hit around USD 27.88 billion by 2034, representing a CAGR of 6.50% from 2025 to 2034. The North America market size was estimated at USD 5.77 billion in 2024 and is expanding at a CAGR of 6.20% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : March 2025
  • Report Code : 3953
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID-19 Impact on Companion Animal Drugs Market 

5.1. COVID-19 Landscape: Companion Animal Drugs Industry Impact

5.2. COVID-19: Impact Assessment for the Industry

5.3. COVID-19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Companion Animal Drugs Market, By Product

8.1. Companion Animal Drugs Market Revenue and Volume Forecast, by Product

8.1.1. Drugs

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Vaccines

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Medicated Feed Additives

8.1.3.1. Market Revenue and Volume Forecast

Chapter 9. Global Companion Animal Drugs Market, By Animal Type

9.1. Companion Animal Drugs Market Revenue and Volume Forecast, by Animal Type

9.1.1. Dogs

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Cats

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Horses

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Others

9.1.4.1. Market Revenue and Volume Forecast

Chapter 10. Global Companion Animal Drugs Market, By Route of Administration 

10.1. Companion Animal Drugs Market Revenue and Volume Forecast, by Route of Administration

10.1.1. Oral

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Injectable

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Topical

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Others

10.1.4.1. Market Revenue and Volume Forecast

Chapter 11. Global Companion Animal Drugs Market, By Distribution Channel 

11.1. Companion Animal Drugs Market Revenue and Volume Forecast, by Distribution Channel

11.1.1. Veterinary Hospitals

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Veterinary Clinics

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Pharmacy and Drug Stores

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. e-commerce

11.1.4.1. Market Revenue and Volume Forecast

Chapter 12. Global Companion Animal Drugs Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Product

12.1.2. Market Revenue and Volume Forecast, by Animal Type

12.1.3. Market Revenue and Volume Forecast, by Route of Administration

12.1.4. Market Revenue and Volume Forecast, by Distribution Channel

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Product

12.1.5.2. Market Revenue and Volume Forecast, by Animal Type

12.1.5.3. Market Revenue and Volume Forecast, by Route of Administration

12.1.5.4. Market Revenue and Volume Forecast, by Distribution Channel

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Product

12.1.6.2. Market Revenue and Volume Forecast, by Animal Type

12.1.6.3. Market Revenue and Volume Forecast, by Route of Administration

12.1.6.4. Market Revenue and Volume Forecast, by Distribution Channel

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Product

12.2.2. Market Revenue and Volume Forecast, by Animal Type

12.2.3. Market Revenue and Volume Forecast, by Route of Administration

12.2.4. Market Revenue and Volume Forecast, by Distribution Channel

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Product

12.2.5.2. Market Revenue and Volume Forecast, by Animal Type

12.2.5.3. Market Revenue and Volume Forecast, by Route of Administration

12.2.5.4. Market Revenue and Volume Forecast, by Distribution Channel

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Product

12.2.6.2. Market Revenue and Volume Forecast, by Animal Type

12.2.6.3. Market Revenue and Volume Forecast, by Route of Administration

12.2.6.4. Market Revenue and Volume Forecast, by Distribution Channel

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Product

12.2.7.2. Market Revenue and Volume Forecast, by Animal Type

12.2.7.3. Market Revenue and Volume Forecast, by Route of Administration

12.2.7.4. Market Revenue and Volume Forecast, by Distribution Channel

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Product

12.2.8.2. Market Revenue and Volume Forecast, by Animal Type

12.2.8.3. Market Revenue and Volume Forecast, by Route of Administration

12.2.8.4. Market Revenue and Volume Forecast, by Distribution Channel

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Product

12.3.2. Market Revenue and Volume Forecast, by Animal Type

12.3.3. Market Revenue and Volume Forecast, by Route of Administration

12.3.4. Market Revenue and Volume Forecast, by Distribution Channel

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Product

12.3.5.2. Market Revenue and Volume Forecast, by Animal Type

12.3.5.3. Market Revenue and Volume Forecast, by Route of Administration

12.3.5.4. Market Revenue and Volume Forecast, by Distribution Channel

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Product

12.3.6.2. Market Revenue and Volume Forecast, by Animal Type

12.3.6.3. Market Revenue and Volume Forecast, by Route of Administration

12.3.6.4. Market Revenue and Volume Forecast, by Distribution Channel

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Product

12.3.7.2. Market Revenue and Volume Forecast, by Animal Type

12.3.7.3. Market Revenue and Volume Forecast, by Route of Administration

12.3.7.4. Market Revenue and Volume Forecast, by Distribution Channel

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Product

12.3.8.2. Market Revenue and Volume Forecast, by Animal Type

12.3.8.3. Market Revenue and Volume Forecast, by Route of Administration

12.3.8.4. Market Revenue and Volume Forecast, by Distribution Channel

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Product

12.4.2. Market Revenue and Volume Forecast, by Animal Type

12.4.3. Market Revenue and Volume Forecast, by Route of Administration

12.4.4. Market Revenue and Volume Forecast, by Distribution Channel

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Product

12.4.5.2. Market Revenue and Volume Forecast, by Animal Type

12.4.5.3. Market Revenue and Volume Forecast, by Route of Administration

12.4.5.4. Market Revenue and Volume Forecast, by Distribution Channel

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Product

12.4.6.2. Market Revenue and Volume Forecast, by Animal Type

12.4.6.3. Market Revenue and Volume Forecast, by Route of Administration

12.4.6.4. Market Revenue and Volume Forecast, by Distribution Channel

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Product

12.4.7.2. Market Revenue and Volume Forecast, by Animal Type

12.4.7.3. Market Revenue and Volume Forecast, by Route of Administration

12.4.7.4. Market Revenue and Volume Forecast, by Distribution Channel

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Product

12.4.8.2. Market Revenue and Volume Forecast, by Animal Type

12.4.8.3. Market Revenue and Volume Forecast, by Route of Administration

12.4.8.4. Market Revenue and Volume Forecast, by Distribution Channel

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Product

12.5.2. Market Revenue and Volume Forecast, by Animal Type

12.5.3. Market Revenue and Volume Forecast, by Route of Administration

12.5.4. Market Revenue and Volume Forecast, by Distribution Channel

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Product

12.5.5.2. Market Revenue and Volume Forecast, by Animal Type

12.5.5.3. Market Revenue and Volume Forecast, by Route of Administration

12.5.5.4. Market Revenue and Volume Forecast, by Distribution Channel

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Product

12.5.6.2. Market Revenue and Volume Forecast, by Animal Type

12.5.6.3. Market Revenue and Volume Forecast, by Route of Administration

12.5.6.4. Market Revenue and Volume Forecast, by Distribution Channel

Chapter 13. Company Profiles

13.1. Indian Immunologicals Ltd

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Agrolabo S.p.A

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Endovac Animal Health

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. HIPRA

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Norbrook Holdings Limited

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Zoetis

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Chanelle Pharma

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Virbac SA

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Vetoquinol

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Merck & Co

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global companion animal drugs market size is expected to increase USD 27.88 billion by 2034 from USD 14.80 billion in 2024.

The global companion animal drugs market will register growth rate of 6.50% between 2025 and 2034.

The major players operating in the companion animal drugs market are Indian Immunologicals Ltd, Agrolabo S.p.A, Endovac Animal Health, HIPRA, Norbrook Holdings Limited, Zoetis, Chanelle Pharma, Virbac SA, Vetoquinol, Merck & Co, Elanco Animal Health, Dechra Pharmaceuticals, Ceva Sante, Boehringer Ingelheim International GmbH, and Others.

The driving factors of the companion animal drugs market are the growing awareness about animal healthcare and rising prevalence of parasitic diseases.

North America region will lead the global companion animal drugs market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client